(VIANEWS) – Shares of Amicus Therapeutics (NASDAQ: FOLD) jumped 7.45% to $9.66 at 15:57 EST on Tuesday, following the last session’s upward trend. NASDAQ is sliding 0.15% to $13,747.94, following the last session’s upward trend. This seems, at the moment, a somewhat down trend exchanging session today.
Amicus Therapeutics’s last close was $9.56, 62.35% under its 52-week high of $25.39.
Today’s last reported volume for Amicus Therapeutics is 1653183 which is 35.94% below its average volume of 2580682.
The company’s growth estimates for the present quarter and the next is 28% and 33.3%, respectively.
Amicus Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 24.2%, now sitting on 281.82M for the twelve trailing months.
Amicus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.32%, a negative 0.61%, and a positive 2.91%, respectively.
Amicus Therapeutics’s highest amplitude of average volatility was 3.33% (last week), 4.22% (last month), and 2.91% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Amicus Therapeutics’s stock is considered to be oversold (<=20).
Amicus Therapeutics’s Stock Yearly Top and Bottom Value
Amicus Therapeutics’s stock is valued at $9.66 at 15:57 EST, way below its 52-week high of $25.39 and way above its 52-week low of $8.60.
Amicus Therapeutics’s Moving Average
Amicus Therapeutics’s worth is way under its 50-day moving average of $11.12 and below its 200-day moving average of $10.29.
More news about Amicus Therapeutics (FOLD).